newest glp-1 medications for type 2 diabetes 2025 Impact: How GLP-1s Are Changing the Treatment Paradigm In the phase 3 ACHIEVE-1

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

For weight management, only semaglutide (Wegovy) and liraglutide (Saxenda) are specifically licensed in the UK, with access typically through specialist weight management services according to NICE criteria

If switching from the pill to injectable, the injection will be administered the day after stopping the pill

The myelin sheath is the lipid-rich coating around the axons of nerve cells

There have been reports that iris darkening is a side effect of using these types of products, though that was never their intended purpose